Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

A guarded yes to Gardasil – and a door open to Cervarix

July 17, 2007 Sales and Marketing

After 18 months of deliberation by an expert committee, the UK government has agreed in principle that girls aged 12-13 …
News

Latest news from Datamonitor

July 16, 2007 Research and Development, Sales and Marketing

Antisoma drops ovarian cancer drugCancer drug developer Antisoma says new data from its Phase II trial of ASA404 showed that …
News

FDA approves first Alzheimer’s patch

July 13, 2007 Sales and Marketing

The FDA has approved Novartis' Exelon Patch, the first ever skin patch treatment for Alzheimer's disease.Novartis said the once-daily treatment …
News

Independent PR agency Chandler Chicco acquired

July 13, 2007 Medical Communications, Sales and Marketing Chandler Chicco, inVentiv Health

The world’s largest private healthcare PR firm Chandler Chicco Agency has been bought out by US marketing group inVentiv Health …
News

Janssen’s Invega approved in Europe

July 12, 2007 Sales and Marketing

Janssen-Cilag's once-daily schizophrenia treatment, Invega, has been granted European approval, making it the first oral, prolonged-release drug for the condition …
News

NICE reverses decision on Alimta

July 11, 2007 Sales and Marketing

Patients with the deadly type of lung cancer called mesothelioma will now be able to receive Lilly's Alimta after NICE …
News

Latest news from Datamonitor

July 9, 2007 Research and Development, Sales and Marketing

Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …
News

Moore’s Sicko documentary launched in US

July 5, 2007 Sales and Marketing EU, US, hc, reform

Michael Moore's new film about the US healthcare system, Sicko, is stirring controversy following its release in cinemas across America …
News

Roche launches $3 billion hostile takeover bid for diagnostics company

July 5, 2007 Sales and Marketing

Roche has launched a hostile takeover bid for cancer diagnostics company Ventana, offering to pay around $3 billion for the …
News

Alzheimer’s sufferers wait for judgment as NICE put in dock

June 28, 2007 Sales and Marketing

Alzheimer's sufferers are just weeks away from finding out if the judicial review of NICE's decision-making will be successful.The High …
News

FDA approves Lyrica for chronic pain condition

June 28, 2007 Sales and Marketing

Pfizer's Lyrica has become the first treatment to be approved in the US for fibromyalgia, a widespread chronic pain condition.Lyrica …
News

GSK’s leukaemia drug closer to European approval

June 28, 2007 Sales and Marketing

GlaxoSmithKline's orphan leukaemia treatment Atriance has been recommended for European approval by a key EMEA committee.Atriance (nelarabine) was given a …
News

Roche strengthens autoimmune franchise with arthritis drug deal

June 28, 2007 Research and Development, Sales and Marketing

Roche has added a novel treatment for rheumatoid arthritis to its early stage pipeline, one it says has the potential …
News

Perfect pitch: has your salesforce got it?

June 25, 2007 Sales and Marketing sales, strategy

Back in the 70s, pharmaceutical sales reps were detail men. They spent more time giving details to doctors about their …
Feature

Latest news from Datamonitor

June 22, 2007 Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026